RECRUITING

Upper Gastrointestinal Endoscopy in HIV-infected Individuals

NCT07425067•Centre Hospitalier Universitaire Saint Pierre

Summary

The aim of this registry is to collect prospectively demographic characteristics and upper gastrointestinal endoscopy diagnoses over a long-term period, in people living with HIV, undergoing upper gastrointestinal endoscopy

Eligibility

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

Locations (1)

CHU Saint Pierre

Brussels, Belgium

Key Dates

Start Date

January 1, 2004

Primary Completion Date

January 1, 2027

Completion Date

January 1, 2027

Last Updated

February 20, 2026

Enrollment

2,500

ESTIMATED participants

Conditions

HIV

Interventions

Gastroscopy

DIAGNOSTIC_TEST

Contacts

Marcel Nkuize, PhD

CONTACT

+32 25354658 marcel.nkuize@stpierre-bru.be

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

View study

RECRUITINGPHASE2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITING